Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy
Authors:
- Giovanni CenderelloGCGiovanni Cenderello
- Ambra PasaAPAmbra Pasa
- Andrea DusiADAndrea Dusi
- Chiara DentoneCDChiara Dentone
- Federica ToscaniniFTFederica Toscanini
- Nicoletta BobbioNBNicoletta Bobbio
- Elisabetta BondiEBElisabetta Bondi
- Valerio Del BonoVBValerio Del Bono
- Manuela IzzoMIManuela Izzo
- Giovanni RiccioGRGiovanni Riccio
- Marco AnselmoMAMarco Anselmo
- Raffaella GiacchinoRGRaffaella Giacchino
Open Access
- 30 May 2013
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1) , 248
Abstract
Background: Visceral Leishmaniasis (VL) is endemic in 88 countries, in areas of relatively low incidence with a relevant proportion of immune suppressed patients clinical presentation, diagnosis and management may present difficulties and pitfalls. Methods: Demographic data, clinical, laboratory features and therapeutic findings were recorded in patients identified by a regional VL disease registry from January 2007 to December 2010. Results: A total of 55 patients (36 adults mean age 48.7 years, 19 children median age 37.5 months) were observed presenting with 65 episodes. All childen were immunocompetent, whereas adults affected by VL included both immunocompetent (n°17) and immunesuppressed (n°19) patients. The clinical presentation was homogeneous in children with predominance of fever and hepato-splenomegaly. A wider spectrum of clinical presentations was observed in immunocompromised adults. Bone marrow detection of intracellular parasites (Giemsa staining) and serology (IFAT) were the most frequently used diagnostic tools. In addition, detection of urinary antigen was used in adult patients with good specificity (90%). Liposomal amphotericin B was the most frequently prescribed first line drug (98.2% of cases) with 100% clinical cure. VL relapses (n°10) represented a crucial finding: they occurred only in adult patients, mainly in immunocompromised patients (40% of HIV, 22% of non-HIV immunocompromised patients, 5,9% of immunocompetent patients). Furthermore, three deaths with VL were reported, all occurring in relapsing immunocompromised patients accounting for a still high overall mortality in this group (15.8%). Conclusions: The wide spectrum of clinical presentation in immunesuppresed patients and high recurrence rates still represent a clinical challenge accounting for high mortality. Early clinical identification and satisfactory treatment performance with liposomal amphotericin B are confirmed in areas with low-level endemicity and good clinical standards. VL needs continuing attention in endemic areas where increasing numbers of immunocompromised patients at risk are dwelling.Keywords
This publication has 35 references indexed in Scilit:
- Role of fine‐needle aspiration cytology in the prompt diagnosis of recurrence of visceral leishmaniasis presented as isolated cervical leishmanial lymphadenopathyDiagnostic Cytopathology, 2011
- Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic ReviewPLOS Neglected Tropical Diseases, 2011
- Pediatric Visceral Leishmaniasis in Albania: A Retrospective Analysis of 1,210 Consecutive Hospitalized Patients (1995–2009)PLOS Neglected Tropical Diseases, 2010
- Asymptomatic Leishmania infantum Infection in an Area of Northwestern Italy (Piedmont Region) Where Such Infections Are Traditionally NonendemicJournal of Clinical Microbiology, 2010
- Spread of Vector-borne Diseases and Neglect of Leishmaniasis, EuropeEmerging Infectious Diseases, 2008
- Incidence and Time Course of Leishmania infantum Infections Examined by Parasitological, Serologic, and Nested-PCR Techniques in a Cohort of Naïve Dogs Exposed to Three Consecutive Transmission SeasonsJournal of Clinical Microbiology, 2006
- Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-upEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Noninvasive Method for Diagnosis of Visceral Leishmaniasis by a Latex Agglutination Test for Detection of Antigens in Urine SamplesJournal of Clinical Microbiology, 2004
- Impact of Highly Active Antiretroviral Therapy on the Incidence of Visceral Leishmaniasis in a French Cohort of Patients Infected with Human Immunodeficiency VirusThe Journal of Infectious Diseases, 2002
- Pediatric Visceral Leishmaniasis in Western Sicily, Italy: A Retrospective Analysis of 111 CasesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002